PBH
Prestige Brand Holdings Inc
NYSE: PBH · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$56.02
-4.65% today
Updated 2026-04-29
Market cap
$2.65B
P/E ratio
14.78
P/S ratio
2.40x
EPS (TTM)
$3.79
Dividend yield
—
52W range
$51 – $89
Volume
0.5M
Prestige Brand Holdings Inc (PBH) Financial statements
SEC filings — annual and quarterly data.
Profit margin
16.90%
Operating margin
29.10%
ROE
10.30%
ROA
6.13%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2006 | $296.67M | $26.28M | 53.00% | 28.28% | 8.86% |
| 2007 | $318.63M | $36.08M | 51.94% | 29.71% | 11.32% |
| 2008 | $326.60M | $33.92M | 51.59% | 27.99% | 10.39% |
| 2009 | $312.71M | $-186.78M | 52.21% | -53.57% | -59.73% |
| 2010 | $302.02M | $32.12M | 52.13% | 26.06% | 10.63% |
| 2011 | $336.51M | $29.22M | 50.78% | 22.63% | 8.68% |
| 2012 | $441.08M | $37.21M | 51.55% | 23.31% | 8.44% |
| 2013 | $623.60M | $65.50M | 55.68% | 30.77% | 10.50% |
| 2014 | $601.88M | $72.61M | 56.50% | 31.34% | 12.06% |
| 2015 | $714.62M | $78.26M | 56.84% | 29.04% | 10.95% |
| 2016 | $806.25M | $99.91M | 57.95% | 32.29% | 12.39% |
| 2017 | $882.06M | $69.39M | 56.72% | 23.31% | 7.87% |
| 2018 | $1.04B | $339.57M | 55.37% | 20.73% | 32.61% |
| 2019 | $975.78M | $-35.80M | 56.94% | 6.92% | -3.67% |
| 2020 | $963.01M | $142.28M | 57.34% | 30.23% | 14.77% |
| 2021 | $943.37M | $164.68M | 58.03% | 31.53% | 17.46% |
| 2022 | $1.09B | $205.38M | 57.11% | 30.36% | 18.90% |
| 2023 | $1.13B | $-82.31M | 55.45% | -1.99% | -7.30% |
| 2024 | $1.13B | $209.34M | 55.49% | 30.43% | 18.60% |
| 2025 | $1.14B | $214.60M | 55.76% | 29.60% | 18.86% |